Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001085331 | SCV000288068 | likely benign | Duchenne muscular dystrophy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000657863 | SCV000345274 | uncertain significance | not provided | 2017-11-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000657863 | SCV000779623 | benign | not provided | 2020-07-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002378993 | SCV002674400 | likely benign | Cardiovascular phenotype | 2020-03-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000657863 | SCV003829546 | uncertain significance | not provided | 2020-10-08 | criteria provided, single submitter | clinical testing |